维普期刊资源整合服务平台（V6.5）

97篇 您的检索式：作者名="RuEGG C"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Endothelial cell integrins and COX-2: mediators and theraputic targets of tumor angiogenesis显示文摘	Ruegg C Dormond O Mariotti A	2004	Biochim Biophys Acta2004，1654，1：	1
2	Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone- resistant cells显示文摘	Ruegg J Holsboer F Turck C	2004	Mol Cell Biol2004，24，：	1
3	Complete and long-lasting re- gression of disseminated multiple skin melanoma metastases under treatment with eyelooxygenase-2 inhibitor 显示文摘	Lejeune FJ Monnier Y Ruegg C	2006	Melanoma Res2006，16，：	1
4	Evidence for the involvement of endothelial cell integrin αvβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ显示文摘	Ruegg C Yimaz A Bieler G	1998	Nat Med1998，4，：	1
5	Recombinant human tumor necrosis factor: an efficient agent for cancer treatment 显示文摘	LEJEUNE FJ RuEGG C	2006	Bull Cancer2006，93，8：	1
6	Antiangiogenic peptides and proteins: from experimental tools to clinical drugs显示文摘	Ruegg C Hasmim M Lejeune FJ	2006	Biochim Biophys Acta2006，1765，2：	1
7	Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells:which side to target?显示文摘	Ruegg C Dormond O Foletti A	2002	Endothelium2002，9，3：	1
8	The tumor microenvironmentand its contribution to tumor evolution toward metasta-sis显示文摘	Lorusso G Ruegg C	2008	Histochem Cell Biol2008，130，6：	1
9	The tumor microenvironment and its contribution to tumor evolution toward metastasis 显示文摘	Lorusso G Ruegg C	2008	Histochem Cell Biol2008，130，6：	1
10	Supp ression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells:which side to target?显示文摘	Ruegg C Dormond O Foletti A	2002	Endothelium2002，9，3：	1
11	The tumor microenvironment and its contribu- tion to tumor evolution toward metastasis 显示文摘	Lorusso G Ruegg C	2008	Histochem Cell Biol2008，130，：	1
12	Non steroidal anti-inflammato-ry drugs and COX-2 inhibitors as anti-cancer therapeutics:hypes,hopes and reality显示文摘	RUEGG C ZARIC J STUPP R	2003	Ann Med2003，35，7：	1
13	Endothelial cell integrins and COX-2:mediators and therapeutic targets of tumor an- giogenesis 显示文摘	Ruegg C Dormond O Mariotti A	2004	Biochimica et Biophysiea Acta2004，1654，1：	1
14	The tumor microenvimnment and its contri- bution to tumor evolution toward metastasis 显示文摘	Lorusso G RUegg C	2008	Histochem Cell Biol2008，130，6：	1
15	Tegaserod,a 5-hydroxytryptamine type 4 receptor partial agonist,is devoid of electrocardiographic effects显示文摘	Morganroth J Ruegg PC Dunger-Baldauf C	2002	Am J Gastroenterol2002，97，：	1
16	Clinical applications of TNF-alpha in cancer显示文摘	Lejeune F J Ruegg C Lienard D		0，，05：	1
17	Endothelial cell integrinsan COX-2:mediators and therapeutic targets of tumor angiogenesis显示文摘	Ruegg C Dormond O Mariotti A	2004	Biochim Biophs Acta2004，1654，1：	1
18	Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis 显示文摘	Irmler M Steiner V Ruegg C	2000	FEBS Letters2000，468，2：	1
19	Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-g显示文摘	Ruegg C Yilmaz A Bieler G	1998	Nat Med1998，4，4：	1
20	The tumor microenvironment and its contri- bution to tumor evolution toward metastasis 显示文摘	Lorusso G Ruegg C	2008	Histochem Cell Biol2008，130，6：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示